Hi Davos, Temcell provides us with royalty payments (earnings).
For US market, I believe Mesoblast wants to market and sell their products directly.
$90m-$144m US expected revenue seems about right but you need to look at the profit (Net Profit After Tax) to calculate P/E; not the revenue as such.
Hi Davos, Temcell provides us with royalty payments...
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 97.0¢ | $2.821M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20688 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 35000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |